May 15 (Reuters) -
TAIKO PHARMACEUTICAL CO LTD
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to
Mar 31, 2009 Mar 31, 2008 Mar 31, 2010
LATEST YEAR-AGO COMPANY
RESULTS RESULTS FORECASTS Sales 5.92 5.30
(+11.8 pct) (+4.7 pct) Operating 718 mln 560 mln
(+28.2 pct) (-6.7 pct) Recurring 720 mln 602 mln
(+19.5 pct) (-22.3 pct) Net 356 mln 292 mln
(+22.0 pct) (+19.2 pct) EPS Y83.94 Y276.53 Diluted EPS Y81.79 Annual div Y5.00 Y10.00 Y2.50 -Q2 div nil nil nil -Q4 div Y5.00 Y10.00 Y2.50
NOTE - Taiko Pharmaceutical Co Ltd is the full company name.
If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half dividend and Q4 to the second-half dividend announced before a new corporate law in 2006 allowed companies to pay and report dividends on a quarterly basis.
For latest earnings estimates made by Toyo Keizai, please double click on 4574.TK1.